Study of buagafuran capsules in people with liver problems
Part of Mental health clinical trials.
This study tests how the body handles a new medicine called buagafuran in people with mild to moderate liver problems compared to people with healthy livers. It helps doctors understand if the dose needs to be adjusted for people with liver issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have either mild to moderate liver problems (Child-Pugh class A or B) or a healthy liver.
- Your weight must be at least 50 kg for men, 45 kg for women, and your body mass index (BMI) must be between 18 and 32.
- Your kidney function must be normal (creatinine clearance at least 60 mL/min).
- If you have liver problems, your condition must be stable and your medications must not need changes for at least 14 days before the study.
- You must agree to use effective birth control from screening until 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called buagafuran for people with generalized anxiety disorder (GAD). It aims to see if the drug can safely reduce anxiety symptoms.
This trial tests a new capsule called Buagafuran for adults with generalized anxiety disorder (GAD). It aims to see if the medication helps reduce anxiety without causing major side effects.
This Phase 3 trial studies Shugan Jieyu Capsule to treat generalized anxiety disorder (GAD). It aims to see if it can reduce anxiety symptoms in people who fit specific anxiety severity and traditional diagnosis criteria.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.